Autonomic Dysfunction Professors and Supervisors | ApplySharif

Find Academic Supervisors

Find and connect with academic supervisors, professors, and scholars for your research journey.

Showing 676-690 of 931 supervisors

Profile data may be stale. It is sourced from public faculty pages.

Bruce SchultzView profile

Professor

Kansas State UniversityUnited States

Dr. Bruce Schultz is a Professor in the Department of Anatomy and Physiology at Kansas State University's College of Veterinary Medicine. With a PhD in Pharmacology from Cornell University (1991), he leads a research laboratory investigating epithelial cell physiology and its implications for cancer and cystic fibrosis. PhD, Pharmacology, Cornell University, 1991 His work focuses on ion transport and barrier function in epithelial cells lining hollow organs. Key projects examine: Physiological mechanisms in male reproductive ducts and their connection to prostate cancer Hormone-sensitive mammary epithelium in relation to breast cancer and mastitis Pharmacological interventions targeting CFTR channels for cystic fibrosis therapy Ion transport modeling in bovine mammary systems Collaborations include: Dr. John Tomich (Biochemistry) - synthetic channel peptides Dr. Ronette Gehring - toxin transport in milk Research supported by: National Institutes of Health United States Department of Agriculture Cystic Fibrosis Foundation Contact: bschultz@ksu.edu | 785-532-4839

Official University Profile

Madhan SubramanianView profile

Associate Professor

Oklahoma State UniversityUnited States

Madhan Subramanian is an Associate Professor in the Department of Physiological Sciences at Oklahoma State University, with a research focus on glial mechanisms of obesity-induced hypertension and aging-related neuroinflammation. His work bridges neuroscience, physiology, and metabolic disease research. PhD in Pathology (Michigan State University, 2011) Postdoctoral Training (Wayne State University, 2014) Academic career: Lecturer at University of Wisconsin-Madison (2014-2017), Assistant Professor at Oklahoma State University (2017-2023), promoted to Associate Professor in 2023 His research investigates glial cell dysfunction in metabolic disorders, including: Obesity-induced sympathetic overactivity Cellular senescence in brainstem and hypothalamus Nrf2-Keap1 redox signaling dysregulation GLP1 brain signaling for cardiovascular control Major grants include NIH R15HL148844, AHA Institutional Research Enhancement Awards, and OCASCR support. His peer-reviewed publications (2020-2025) explore neuroinflammation, thermogenic metabolism, and HSV-1 neurodegeneration. Awards include the Zoetis Outstanding Researcher (2021) and American Physiological Society Research Recognition (2019).

Official University Profile

James GalliganView profile

Professor

Michigan State UniversityUnited States

James Galligan is a Professor at Michigan State University, affiliated with the BioMolecular Science Gateway, Neuroscience Program, and Cell & Molecular Biology Program. His research focuses on the enteric nervous system and gastrointestinal physiology, with extensive expertise in electrophysiological, optogenetic, immunohistochemical, and confocal microscopy imaging techniques. Dr. Galligan's research spans multiple interconnected fields: Autonomic neurotransmission in the gastrointestinal tract Synaptic mechanisms in the enteric nervous system (ENS) Gastrointestinal motility control systems Enteric nervous system physiology and pharmacology Synaptic and neuromuscular transmission using microelectrode recording Hypertension and vascular function His laboratory conducts ex vivo and in vivo measurements of gastrointestinal motility and enteric neurophysiology in genetically-modified animal models of gastrointestinal disorders. Dr. Galligan's work bridges neuroscience, pharmacology, and gastrointestinal physiology, with particular emphasis on understanding how neurotransmission regulates gut function through receptors including serotonin, opioid, and purinergic systems. His publication record demonstrates sustained research activity spanning several decades, with recent work through 2025 focusing on receptor mechanisms in the ENS. His research has significant implications for understanding and treating gastrointestinal disorders including irritable bowel syndrome, functional dyspepsia, and other motility disorders. The consistent output across multiple disciplines indicates a highly productive research program with translational potential.

Official University Profile

Linda PiacentineView profile

Associate Professor

Marquette UniversityUnited States

Linda Piacentine, Ph.D., RN, ACNP-BC is an Associate Professor in the College of Nursing at Marquette University . She specializes in symptom self-management for chronic diseases, exercise interventions for cancer and multiple sclerosis survivors, and improving intimate partner violence (IPV) screening practices in primary care clinics. Ph.D., Marquette University (2010) Certified Acute Care Nurse Practitioner (ACNP-BC) Her research explores: Psychological and physiological impacts of long COVID Team-based exercise programs for cancer survivors Psychosocial factors in methadone maintenance therapy Community-academic partnerships to enhance IPV screening Recent publications focus on inflammation in aging, discharge teaching methodologies, and neurophysiological responses to substance use. Awards include 2021-2025 AHPRC Research Fellow and 2018 Midwest Nursing Research Society Best Faculty Paper . She has received grants from Advancing a Healthier Wisconsin Endowment and Clinical and Translational Science Institute . Dr. Piacentine is affiliated with: American Association of Nurse Practitioners Midwest Nursing Research Society Sigma Theta Tau International

Official University Profile

Marko Petteri RosenholmView profile

Lecturer

University of HelsinkiFinland

Marko Petteri Rosenholm serves as University Lecturer at the Faculty of Pharmacy, University of Helsinki, and Supervisor in the Doctoral Programme in Drug Research. His academic work spans neuroscience, biomedical sciences, and pharmacy with emphasis on neuropharmacological mechanisms and brain fluid dynamics. His research focuses on glymphatic system functionality, cerebrospinal fluid dynamics, and neuropharmacology of pain/anesthesia. Key investigations include heart failure's impact on brain clearance, spinal morphine-α2 agonist interactions, anesthesia effects on glymphatic flow, and nitrous oxide's antidepressant mechanisms via TrkB activation. Rodent models form the core methodology across these studies. Recent publications (2024-2025) reveal consistent exploration of physiological modulators (CO 2 , temperature, cardiac function) on brain fluid dynamics and drug efficacy. This work bridges fundamental neuroscience with clinical applications in anesthesia, pain management, and depression treatment. As doctoral supervisor, he mentors PhD candidates in drug research. He actively participates in a Finnish Medical Foundation-funded project (2025-2027) with Tomi Lilius and Teemu Lohela, likely extending his neuropharmacological investigations. His conference participation includes ECNP Congress (2019), FENS Forum (2018), and Gordon Research Conferences.

Official University Profile

Vegard Bruun Bratholm WyllerView profile

Professor

University of OsloNorway

Vegard Bruun Bratholm Wyller is a Professor at the Department of Clinical Medicine, University of Oslo, and Head of Research at the Department of Pediatrics, Akershus University Hospital. A qualified physician (1998) with specialization in pediatrics (2009), he completed his PhD on chronic fatigue syndrome (CFS/ME) in adolescents (2007). He leads the international COFFI consortium (Collaborative on Fatigue Following Infection) since 2019 and has spearheaded three major Long COVID research projects. Professor, Department of Clinical Medicine, University of Oslo Head of Research, Department of Pediatrics, Akershus University Hospital Specialist in Pediatrics His research focuses on chronic fatigue syndromes, particularly CFS/ME and post-infectious fatigue, with an emphasis on disease mechanisms, diagnostics, and treatment. He also conducts cardiac research on children with murmurs and autonomic regulation in heart transplant recipients. His work in Long COVID includes RNA sequencing, microbiota analysis, and neurological outcomes. Recent publications highlight his team’s exploration of post-COVID-19 fatigue risk factors, rehabilitation programs, and microbiota interactions. His studies bridge clinical pediatrics with immunology, neurology, and autonomic physiology, contributing to understanding fatigue mechanisms across infections.

Official University Profile

Alexander RabchevskyView profile

Professor

University of KentuckyUnited States

Dr. Alexander "Sasha" Rabchevsky is a Professor of Physiology at the University of Kentucky and an inaugural member of the Spinal Cord and Brain Injury Research Center (SCoBIRC) . He combines neurophysiology with mitochondrial biology to develop innovative therapies for spinal cord injury (SCI). His research focuses on autonomic pathophysiology and bioenergetic restoration through mitoceuticals and mitochondrial transplantation. B.S. in Biology from Hampden-Sydney College (1988) Ph.D. in Neuroscience from University of Florida (1995) Postdoctoral training at INSERM U421, University of Paris XII Rabchevsky's research program investigates: Abnormal neural circuitry causing autonomic dysreflexia and muscle spasticity after SCI Mitochondrial dysfunction as a therapeutic target Mitoceutical interventions for preserving synaptic mitochondria Intraspinal mitochondria transplantation using hydrogel delivery systems His recent publications highlight mitochondrial bioenergetics and neuroimmunological interactions in SCI. Key collaborators include Dr. Stephen W. Scheff and Dr. Peter G. Sullivan. Scientific contributions include: Conquer Paralysis Awards for innovative SCI research 2018 Nature Metabolism nomenclature standard for mitochondrial transplantation He leads the Physiology Lab at SCoBIRC, conducting 24/7 telemetric cardiophysiology monitoring and Nanopore sequencing of injury-induced gene expression changes.

Official University Profile

Cedric WilliamsView profile

Professor

University of VirginiaUnited States

Cedric Williams is a Professor of Psychology at the University of Virginia, specializing in Systems and Behavioral Neuroscience. His research bridges experimental psychology and neurobiology through innovative rodent model applications. His primary research domains include: Development of automated behavioral protocols for rodent bio-detection of explosives and hazardous chemical agents Neurobiological investigation of memory encoding mechanisms during emotionally arousing events Mapping neural circuit interactions between the amygdala, prefrontal cortex, and hippocampus Identification of neurochemical transmitters involved in memory storage processes Analysis of his 15 most recent publications reveals a sustained focus on the intersection of peripheral arousal systems and central memory processing. His work consistently employs multimodal methodologies including behavioral learning paradigms, immunocytochemistry, and neurochemical assays. A distinctive pattern emerges in his exploration of vagus nerve-adrenergic-amygdala pathways, demonstrating how peripheral physiological changes translate into neural modifications for memory consolidation. Recent studies increasingly incorporate translational models for cognitive deficits in medical procedures. No scientific awards were documented in the provided materials. Dr. Williams directs a specialized laboratory that integrates computer-automated training systems with neurobiological techniques. His team maintains dual research trajectories: one developing efficient scent-detection protocols for Gambian rats, and another dissecting molecular memory mechanisms. The lab consistently publishes in high-impact neuroscience journals, with recent collaborations extending into medical model systems involving cardiopulmonary bypass and seizure pathology.

Official University Profile

Anthony DownsView profile

Researcher

University of North Carolina at Chapel HillUnited States

Anthony Downs is a Researcher in the Department of Pharmacology at the UNC School of Medicine. His work focuses on neurobiological mechanisms underlying substance use disorders and neurodegenerative diseases, particularly examining the locus coeruleus and basolateral amygdala. He is affiliated with the McElligott Lab. Neurobiology of Opioid Use Disorder Locus Coeruleus Plasticity Dopamine Signaling in Dystonia Neuroimmune Pathways Dr. Downs investigates how neuroplasticity in noradrenergic and dopaminergic systems contributes to addiction and neurodegenerative disease progression. His recent publications highlight interactions between tauopathy and alcohol consumption, opioid withdrawal effects on affective states, and cholinergic-dopaminergic receptor dynamics in dystonia models. Research employs in vivo models, electrophysiology, and molecular profiling. Key publication trends span Neuroscience, Neuropharmacology, and Neurogenetics, with subfields covering opioid relapse mechanisms, locus coeruleus excitability, striatal signaling pathways, and neuroimmune interactions. Notable journals include Neurobiology of Disease , Addictive Neuroscience , and Neuroscience .

Official University Profile

Daniela PalombaView profile

Professor

University of PaduaItaly

Daniela Palomba, MD is a Full Professor of Clinical Psychology at the Department of General Psychology, University of Padova . She has held leadership roles including Deputy Head of the Department (2013-17), Dean of the Faculty of Psychology (2008-11), and Director of the Psychophysiology Service at the Laboratories for Applied and Clinical Psychological Research since 2000. Key Affiliations: NIMH-Center for the Study of Emotion and Attention (University of Florida), HARVESt Study (Hypertension and Ambulatory Recording Venetia), CIRMANMEC (Center for Research Models on Neuropsychic Disorders in Clinical Medicine), CNC (Center of Cognitive Neuroscience). Research Overview: Focuses on psychophysiological mechanisms of emotion and anxiety disorders, including autonomic (HRV) and central (EEG, ERPs) nervous system correlates of affective dispositions like freezing/fainting responses (vaso-vagal syncope, blood-phobia), white-coat hypertension, and depressive symptoms linked to cardiovascular disorders. Implements biofeedback/neurofeedback interventions for autonomic dysfunctions in PTSD, depression, and attention deficits.

Official University Profile

Bowen LiView profile

Assistant Professor

University of TorontoCanada

Bowen Li is an Assistant Professor at the University of Toronto, affiliated with the Leslie Dan Faculty of Pharmacy and cross-appointed in the Institute of Biomedical Engineering and Department of Chemistry. His research focuses on high-throughput development of nanoparticles for RNA medicine delivery, leveraging combinatorial chemistry and artificial intelligence (DSAI) to accelerate material design and screening. He holds a PhD from the University of Washington (2019) and completed postdoctoral studies at MIT (2019–2022). **Research Interests:** Biological Chemistry, Organic Chemistry, and Polymer/ Material Chemistry. His lab pioneers DSAI-driven platforms for lipid nanoparticle (LNP) design, enabling rapid synthesis and screening of thousands of lipid variants for tissue-specific nucleic acid delivery. Key innovations include autonomous discovery systems like LUMI-lab and modular synthesis strategies for biodegradable ionizable lipids. **Articles Trends:** Recent work emphasizes mRNA delivery optimization, lung-targeted therapies, and immunomodulatory materials. Over 15 publications (2023–2025) highlight advancements in nanoparticle design, organ-specific targeting, and overcoming therapeutic resistance in cancer and cardiovascular contexts. **Awards:** None explicitly stated in provided texts. **Grants/Advising:** Details not provided. **Labs/Teams:** Leads the Li Research Group at U of T, integrating data science and biomaterials for RNA nanomedicine applications in vaccines, immunotherapy, and regenerative medicine.

Official University Profile

Bingzhong XueView profile

Professor

Georgia State UniversityUnited States

Bingzhong Xue is a Professor of Biology at Georgia State University's College of Arts & Sciences. She holds a Ph.D. in Nutrition from the University of Tennessee Knoxville (2000) and completed postdoctoral training at Pennington Biomedical Research Center (2000-2003) and Beth Israel Deaconess Medical Center/Harvard Medical School (2003-2007). Before joining Georgia State in 2012, she was an Assistant Professor of Internal Medicine at Wake Forest University Health Sciences. Education: Ph.D. in Nutrition, University of Tennessee at Knoxville, 2000 Postdoctoral Fellow, Pennington Biomedical Research Center, 2000-2003 Postdoctoral Fellow, Beth Israel Deaconess Medical Center/Harvard Medical School, 2003-2007 Research Focus: Her work centers on obesity pathophysiology and metabolic diseases, particularly: Regulation of energy homeostasis Brown/beige adipocyte biology Autonomic nervous system control of metabolic tissues Macrophage inflammation in metabolic disorders Research Trends: Recent work emphasizes epigenetic mechanisms (DNA methylation/histone modifications), endothelial-MerTK pathways in atherosclerosis, gut-adipose crosstalk, and ethanol-induced liver injury. Over 80 publications demonstrate cross-disciplinary focus spanning molecular biology, animal models, and clinical implications. Labs & Facilities: Based in Georgia State's Science Annex and Natural Science Center, her lab investigates adipose tissue physiology, metabolic inflammation, and epigenetic therapies. Collaborates across departments on translational obesity research.

Official University Profile

Brian AnView profile

Associate Professor

University of IowaUnited States

Brian An, PhD, is an Associate Professor at the University of Iowa's College of Education, affiliated with the Lindquist Center. His research focuses on cardiovascular diseases with an emphasis on atrial fibrillation management, syncope mechanisms, and clinical outcomes in geriatric populations. He holds a PhD from the University of Wisconsin, Madison. Research Interests: Dr. An's work spans artificial intelligence applications in cardiology, anticoagulation strategies for atrial fibrillation patients, and improving clinical outcomes through evidence-based practices. His studies often utilize large registries like GLORIA-AF to analyze real-world treatment patterns and patient outcomes. Recent Trends in Publications: His articles emphasize the interplay between chronic conditions (e.g., diabetes, renal dysfunction) and cardiovascular risks, as well as the evolving role of technology in arrhythmia management. He has contributed to guidelines on exercise safety for patients with genetic arrhythmias and explored disparities in atrial fibrillation care across demographic groups. Professional Affiliations: Active in multidisciplinary collaborations, Dr. An's work bridges cardiology, epidemiology, and healthcare informatics. He contributes to American Heart Association scientific statements on topics like post-COVID cardiovascular dysautonomia and sleep-disordered breathing impacts.

Official University Profile

Qing-Hui ChenView profile

Professor

Michigan Technological UniversityUnited States

Qing-Hui Chen is a Professor in the Department of Kinesiology and Integrative Physiology at Michigan Technological University, with affiliations in Biological Sciences and Biomedical Engineering. He holds a PhD from Kagawa University Medical School (Japan), an MS from Southeast University Medical School (China), and an MD from Nantong University College of Medicine (China). His research focuses on cardiovascular physiology, neurophysiology, and exercise science, particularly neural mechanisms of cardiovascular diseases, metabolic disorders, and exercise’s role in autonomic regulation. Key funding includes NIH grants as PI for projects on neural mechanisms of sympathetic activation in heart failure and hypertension. His work spans studies on ethanol metabolism (e.g., acetate’s role in neurotoxicity), orexin system regulation in hypertension, and the impact of gut microbiota on autonomic nervous system function. He collaborates on engineered cardiac patches and investigates microRNA in plant systems. Chen’s presentations address topics like ethanol metabolites’ effects on cardiovascular function and sympathetic nerve activity modulation. He teaches advanced physiology courses and leads the Cardiovascular Physiology Laboratory. Ongoing research explores brain-derived extracellular vesicle roles in hypertension and neuroinflammation.

Official University Profile

Fen-Biao GaoView profile

Professor

University of Massachusetts Chan Medical SchoolUnited States

Fen-Biao Gao is a Professor of RNA Therapeutics and Neurology at the University of Massachusetts Chan Medical School, holding the Paul Cellucci Chair in Neuroscience Research since 2017. He directs the Frontotemporal Dementia Research Center and is affiliated with the RNA Therapeutics Institute. Previously, he held roles at UCSF’s Gladstone Institute of Neurological Disease from 2000–2010. Education: PhD in RNA Biology from Duke University (1995), postdoctoral training at University College London (1995–1997) and UCSF (1997–2000). Research Focus: Investigates molecular mechanisms underlying FTD and ALS using Drosophila, mouse models, and patient-derived iPSCs. Key areas include RNA metabolism, polydipeptide repeat toxicity, and therapeutic interventions targeting C9ORF72 and TDP-43 pathways. His lab employs multidisciplinary approaches (molecular/cellular biology, genetics, and neurobiology). Recent Trends in Publications: Focuses on translational research linking basic molecular mechanisms (e.g., RNA repeats, autophagy defects) to neurodegenerative phenotypes. Highlights include CRISPR-based therapies, biomarker discovery, and drug targets like PIKFYVE inhibitors. Studies emphasize cross-talk between RNA dysfunction and cellular pathways (e.g., mitochondrial function, stress granules). Awards: NIH Javits Award (2018), McKnight Neuroscience Award (2002), and multiple fellowships. Active in professional service, including advisory roles for the Association for Frontotemporal Degeneration and Muscular Dystrophy Association. Lab & Collaborations: Current lab members include postdocs (e.g., Gopinath Krishnan, Soojin Lee) and graduate students. Collaborations span iPSC modeling, drug development, and genetic screening. Active in organizing conferences on RNA metabolism in neurodegenerative diseases.

Official University Profile